India is considering a government proposal to subject antimicrobial drugs to tighter central checks, with the aim of strengthening how these products are assessed before or during clearance. Coverage from multiple outlets says the ministry is focusing on the need for formal evaluations tied to quality, safety and effectiveness.

The Economic Times describes the move as the government mulling tighter scrutiny of antimicrobial drugs, framing it around increased oversight. NDTV reports that under the proposal, the absence of such assessments could affect the quality, safety and efficacy of antimicrobial products, highlighting the rationale for introducing stronger review requirements.

Across the two reports, the common thread is increased central oversight and the importance of structured assessments to support drug quality, safety and efficacy. The sources provided do not specify timelines, exact regulatory mechanisms, or which stages of the approval or monitoring process would change.